Nectar Lifesciences Update by Epic Research

Nectar Lifesciences (NecLife) has touched a significant milestone by receiving second European cGMP (Current Good Manufacturing Practices) approval for its Cephalosporin Finished Dosage Forms (FDF) manufacturing facility in Baddi, Himachal Pradesh. NecLife has received second European cGMP compliance certification for both Oral & Injectables Cephalsporins followed by the successful inspection by the Portugal Authority – National Authority of Medicines and Health Products, Infarmed in July 2013. The Infarmed Certificate is accepted by all EU Health Authorities and by authorities of several other countries.



For Real Time News & Trading Trends Keep Liking Epic Research Private Limited



Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+

Posted in: Indian Market Tips